Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus [Phase 4]
Phase 4 trial evaluating vorapaxar as add-on antiplatelet therapy in patients with and without diabetes mellitus in the setting of myocardia…
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Glucose Measurement Using Microneedle Patches [NA]
Clinical trial update on glucose measurement using microneedle patches for diabetes; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD [Phase 4]
Phase 4 trial evaluating the effect of SGLT2 inhibition on OCT-A parameters in diabetic kidney and retinal disease.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves [Phase 2]
Phase 2 trial evaluating cebranopadol for efficacy and safety in diabetic neuropathic pain; results completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women [Phase 2]
Phase 2 trial examining worksite wellness interventions and their effects on vascular function, insulin sensitivity, and HDL in overweight o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial [Phase 3]
Phase 3 clinical trial SHINE evaluated insulin-based management for hyperglycemia in acute ischemic stroke; results completed and posted in …
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations [Phase 2]
Phase 2 clinical trial investigating whether thyroid hormone can induce non-insulin mediated glucose disposal in individuals with insulin re…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study
Post-trial follow-up results from the Anglo-Scandinavian Cardiac Outcomes Trial assessing long-term cardiovascular outcomes in hypertension …
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study
Pivotal study update for the Lucica glycated albumin–L clinical program in diabetes; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes [NA]
Clinical trial update on a novel microprobe array continuous glucose monitor for type 1 diabetes; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating topically applied bisphosphocin Nu-3 for infected diabetic ulcers in adults with diabetes; study complet…
-
FDA approval · 2019-11-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2019-11-15FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a Supplemental Application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2019-11-15FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved Novo Nordisk's supplemental application for NOVOLIN R (human insulin).
-
FDA approval · 2019-11-15FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2019-11-15FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for APIDRA (insulin glulisine) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2019-11-15FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA label_change · 2019-11-15FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) submitted by Novo Nordisk; the snippet does not specify the exact …
-
FDA label_change · 2019-11-15FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Tresiba (insulin degludec) filed by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: The Pitt Retiree Study: A Diabetes Prevention Program for Medicare Eligible Older Adults [NA]
Clinical trial update for a diabetes prevention program in Medicare-eligible older adults, studying obesity, cardiovascular risk factors, an…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus [Phase 1]
Phase 1 trial update of KQ-791 in Type 2 diabetes assessing safety, tolerability, PK and PD across multiple ascending doses. Completed with …
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Lidocaine for Diabetic Peripheral Neuropathy [NA]
A completed clinical trial investigating lidocaine for diabetic peripheral neuropathy with results posted in 2019.
-
CLINICAL_TRIALS research · 2019-10-30Clinical Trial Update: Community Servings: Food as Medicine for Diabetes [NA]
Clinical trial update for a diabetes study evaluating Food as Medicine delivered by Community Servings, completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina [Phase 4]
Phase 4 trial updating on antiischemic effects of empagliflozin in diabetic patients with refractory angina.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients [Phase 4]
Phase 4 trial examining whether periodontal therapy improves glycemic control in patients with diabetes.